b
r
c
three
ionic
liquid
bmim
bf
dope
mol
licl
bmim
bf
licl
n
n
n
ntetramethylguanidinium
trifluoroacet
tmgt
n
n
n
ntetramethylguanidinium
triflat
tmgt
f
found
use
catalyst
solvent
control
isatin
investig
reveal
reaction
isatin
indol
bmim
bf
licl
tmgt
f
media
stop
step
addit
two
compon
provid
ionic
liquid
tmgt
run
reaction
accompani
friedelcraft
substitut
afford
symmetr
take
advantag
differ
effect
ionic
liquid
reaction
progress
plan
twostep
protocol
effici
synthesi
unsymmetr
versatil
properti
varieti
avail
ionic
liquid
made
promis
substanc
applic
chemistri
area
ionic
liquid
new
gener
solvent
compos
bulki
organ
cation
liquid
rang
ator
close
room
temperatur
henc
well
posit
fill
polar
gap
molecular
liquid
molten
metal
salt
uniqu
natur
ionic
liquid
allow
virtual
possibl
interact
solut
ion
thu
abil
dissolv
organ
inorgan
materi
hand
high
polar
ionic
liquid
ensur
immisc
mani
organ
solvent
offer
uniqu
opportun
phase
separ
recycl
import
featur
ionic
liquid
possibl
tune
chemic
properti
also
adjust
solubl
enabl
phase
separ
today
ionic
liquid
shown
simpl
solvent
show
signific
role
control
reaction
catalyst
earli
use
ionic
liquid
catalyst
mere
base
role
polar
media
facilit
organ
reaction
polar
transit
state
applic
extend
socal
taskspecif
ionic
liquid
either
immobil
effect
ionic
catalyst
ionic
liquid
incorpor
function
group
respons
catalysi
ionic
partner
synthesi
aid
immobil
metal
catalyst
ionic
liquid
recent
receiv
consider
attent
liquid
phase
synthesi
retain
advantag
homogen
catalysi
still
permit
fairli
facil
purif
product
recycl
catalyst
continu
studi
direct
toward
use
ionic
liquid
catalyst
synthesi
organ
compound
licl
n
n
n
ntetramethylguanidinium
trifluoroacet
tmgt
n
n
n
ntetramethylguanidinium
triflat
tmgt
f
promot
reaction
isatin
indol
provid
catalyt
control
synthes
symmetr
un
isatin
privileg
lead
molecul
design
potenti
bioactiv
agent
deriv
shown
possess
broad
spectrum
bioactiv
mani
assess
antihiv
antivir
antitumor
antifung
antiangiogen
anticonvuls
antiparkinson
diseas
therapeut
effect
sar
coronaviru
proteas
inhibitor
interest
properti
prompt
mani
effort
toward
synthesi
pharmacolog
screen
isatin
deriv
investig
oxindol
moieti
recogn
biolog
activ
framework
oxindol
integr
constitu
mani
natur
product
thu
surpris
access
sever
member
class
may
goal
mani
research
laboratori
oxindol
deriv
prepar
reaction
isatin
deriv
barbitur
acid
aromat
triflic
acid
pyrazolon
rout
form
reaction
isatin
indol
acid
condit
sever
method
develop
synthesi
compound
hand
number
oxindol
alkaloid
hydroxyl
substitu
posit
possess
variou
bioactiv
synthes
varieti
method
isatin
found
sluggish
natur
essenti
friedelcraft
reaction
recognit
impli
reaction
could
assist
enhanc
nucleophil
charact
indol
basic
media
activ
carbonyl
group
isatin
aid
acid
speci
view
envisag
acidbas
guanidinium
ionic
liquid
could
suitabl
choic
perform
dual
role
initi
trial
model
reaction
indol
isatin
tmgt
f
encourag
proce
smoothli
room
temperatur
stop
stage
monoindolyl
isatin
afford
fairli
high
yield
also
perform
model
reaction
either
neutral
ionic
liquid
bmim
cl
bmim
bf
absenc
ionic
liquid
respond
issu
high
polar
tmgt
f
respons
catalysi
reaction
note
model
reaction
proceed
either
imidazolium
ionic
liquid
absenc
confirm
function
role
tmgt
f
catalysi
reaction
learn
function
expect
li
could
play
role
h
tmgt
f
intend
test
model
reaction
bmim
bf
dope
licl
expect
licl
contain
bmim
bf
effici
catalyz
addit
indol
onto
isatin
provid
minut
tabl
sever
indol
isatin
deriv
electron
donor
electron
withdraw
substitu
likewis
underw
reaction
effici
ionic
liquid
tmgt
f
bmim
bf
licl
result
summar
tabl
compound
form
sole
condit
contamin
product
even
equiv
indol
employ
reaction
delight
result
intend
examin
effect
anoth
guanidinium
ionic
liquid
purpos
reaction
involv
mmol
ratio
isatin
indol
similarli
carri
n
n
n
ntetramethylguanidinium
trifluoroacet
tmgt
place
tmgt
f
room
temperatur
monitor
reaction
tlc
reveal
rather
slow
disappear
reactant
compar
reaction
tmgt
f
bmim
bf
licl
still
signifi
effici
convers
give
hour
format
byproduct
obvious
account
capabl
tmgt
catalyz
friedelcraft
reaction
anoth
indol
molecul
meanwhil
show
need
optim
condit
gain
better
yield
order
optim
reaction
condit
perform
model
reaction
use
differ
quantiti
reactant
ionic
liquid
best
result
obtain
mmol
ratio
isatin
indol
presenc
ml
tmgt
room
temperatur
therefor
set
method
compris
room
temperatur
reaction
mixtur
indol
isatin
without
use
solvent
addit
catalyst
tmgt
therebi
obtain
fairli
high
yield
tabl
electron
donor
well
electron
withdraw
substitu
exert
consider
effect
reactiv
reactant
catalysi
tmgt
condens
indol
isatin
deriv
better
ration
initi
nucleophil
addit
indol
onto
keton
carbonyl
group
isatin
yield
correspond
dehydr
adduct
give
intermedi
subsequ
undergo
nucleophil
addit
second
indol
molecul
provid
final
product
scheme
next
phase
investig
plan
take
advantag
differ
catalyt
activ
tmgt
tmgt
f
synthesi
unsymmetr
control
manner
protocol
initi
synthes
reaction
isatin
derivatv
indol
tmgt
f
bmim
bf
licl
ionic
liquid
treat
equiv
anoth
indol
deriv
tmgt
give
desir
unsymmetr
result
applic
procedur
summar
tabl
tabl
synthesi
symmetr
indolyl
indol
isatin
deriv
tmgt
scheme
propos
mechan
reaction
isatin
indol
deriv
ionic
liquid
demonstr
applic
three
ionic
liquid
synthesi
symmetr
unsymmetr
biolog
interest
room
temperatur
reaction
indol
isatin
deriv
even
mole
ratio
catalysi
either
tmgt
f
bmim
bf
licl
ionic
liquid
gave
sole
adduct
fairli
high
yield
room
temperatur
similar
reaction
tmgt
favor
form
sole
symmetr
also
devis
reaction
adduct
indol
tmgt
synthes
unsymmetr
room
temperatur
experiment
simplic
associ
high
yield
product
recycl
ionic
liquid
short
reaction
time
render
method
present
highli
competit
compar
exist
procedur
believ
simpl
novel
method
present
could
broad
interest
synthet
medicin
chemist
solvent
reagent
purchas
fluka
merck
chemic
compani
melt
point
measur
electrotherm
apparatu
uncorrect
ir
spectra
obtain
kbr
disc
shimadzu
spectromet
h
c
nmr
spectra
measur
brucker
avanc
spectromet
chemic
shift
h
c
nmr
spectra
express
part
per
million
downfield
tetramethylsilan
mass
spectra
record
shimadzu
mass
spectromet
oper
ioniz
potenti
ev
element
analys
c
h
n
perform
use
foss
herau
chnorapid
analyz
g
mmol
ad
ml
mixtur
heat
reflux
h
cool
room
temperatur
obtain
oili
product
separ
reaction
mixtur
decant
wash
etoac
ml
solvent
collect
organ
phase
remov
reduc
pressur
give
chlorid
bmim
cl
second
step
bmim
cl
g
mmol
dissolv
anhydr
aceton
ml
ad
libf
g
mmol
mixtur
stir
h
room
temperatur
get
solut
store
c
day
refriger
give
excess
dissolv
licl
crystal
precipit
separ
precipit
licl
crystal
g
mmol
solvent
filter
solut
remov
reduc
pressur
therebi
ionic
liquid
tetrafluorobor
dope
mol
licl
bmim
bf
licl
obtain
yellow
oil
mixtur
indol
mmol
isatin
deriv
mmol
ad
vial
contain
magnet
stir
bar
ionic
liquid
tmgt
f
bmim
bf
licl
ml
reaction
mixtur
seal
stir
room
temperatur
disappear
start
materi
min
bmim
bf
licl
min
tmgt
f
monitor
tlc
silica
gel
use
mixtur
ethyl
acetatenhexan
complet
reaction
residu
wash
ml
cold
water
extract
ionic
liquid
solid
residu
recrystal
ethanol
afford
pure
product
ionic
liquid
recov
aqueou
extract
evapor
water
reduc
pressur
reus
next
cycl
known
product
spectral
physic
data
consist
report
literatur
well
sampl
prepar
previous
report
method
mixtur
indol
mmol
isatin
deriv
mmol
ad
vial
contain
magnet
stir
bar
ionic
liquid
tmgt
ml
reaction
mixtur
seal
stir
room
temperatur
isatin
deriv
complet
consum
h
monitor
tlc
silica
gel
use
mixtur
ethyl
acetatenhexan
complet
reaction
result
past
wash
ml
cold
water
extract
ionic
liquid
remain
crude
product
crystal
ethanol
recov
ionic
liquid
aqueou
filtrat
evapor
reduc
pressur
tmgt
remain
nonvolatil
oil
evapor
vessel
collect
reus
novel
product
character
ir
h
nmr
c
nmr
mass
spectral
data
well
element
analysi
partial
assign
spectral
data
given
follow
section
mixtur
oxindol
mmol
indol
deriv
mmol
ad
vial
contain
magnet
stir
bar
tmgt
ml
reaction
mixtur
seal
stir
room
temperatur
disappear
start
materi
h
monitor
tlc
silica
gel
use
mixtur
ethyl
acetatenhexan
complet
reaction
residu
wash
ml
cold
water
extract
tmgt
remain
crude
product
recrystal
ethanol
tmgt
recov
aqueou
extract
evapor
water
reduc
pressur
reus
next
cycl
partial
assign
spectral
data
structur
previous
unreport
product
given
follow
section
compound
ident
g
